FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038523710> ?p ?o ?g. }

• W2038523710 endingPage "1393" @default.
• W2038523710 startingPage "1385" @default.
• W2038523710 abstract "Background. The efficacy of doxycycline for treating the causal agent of human lymphatic filariasis, Brugia malayi, is unknown. Standard treatment with diethylcarbamazine-albendazole is associated with adverse reactions. We assessed whether doxycycline alone or in combination with diethylcarbamazine-albendazole would lead to sustained amicrofilaremia and reduced incidence of adverse reactions. Methods. A double-blind, randomized, placebo-controlled 6-week field trial of doxycycline treatment (100 mg/day) of 161 persons infected with B. malayi was conducted. Four months after receiving doxycycline (n=119) or placebo (n=42), participants received diethylcarbamazine (6 mg/kg) plus albendazole (400 mg) or a matching placebo. Adverse reactions were assessed 48 and 60 h after administration of diethylcarbamazine-albendazole. Treatment efficacy was evaluated at 2, 4, and 12 months after the initial doxycycline treatment. Results. Four months after beginning doxycycline treatment, Wolbachia loads were reduced by 98%. Doxycycline treatment reduced the prevalence of microfilaremia at 2, 4, and 12 months of follow-up (P<.001 for all time points). At the 1-year follow-up, prevalence was reduced by 77% and 87.5% in patients receiving doxycycline alone or doxycycline plus diethylcarbamazine-albendazole, respectively. In contrast, the reduction of microfilaremia in the group receiving placebo doxycycline plus diethylcarbamazine-albendazole was merely 26.7%. Adverse reactions were lowest in the group receiving doxycycline plus placebo diethylcarbamazine-albendazole and highest in the group receiving placebo doxycycline plus diethylcarbamazine-albendazole. The proportion of persons with high fever and severe adverse reactions was significantly reduced in the group treated with doxycycline plus diethylcarbamazine-albendazole. Conclusions. A 6-week course of doxycycline, either alone or in combination with diethylcarbamazine-albendazole, leads to a decrease in microfilaremia and reduces adverse reactions to antifilarial treatment in B. malayi—infected persons." @default.
• W2038523710 created "2016-06-24" @default.
• W2038523710 creator A5014550438 @default.
• W2038523710 creator A5024279527 @default.
• W2038523710 creator A5036900827 @default.
• W2038523710 creator A5056925040 @default.
• W2038523710 creator A5060467891 @default.
• W2038523710 creator A5073074999 @default.
• W2038523710 creator A5074193742 @default.
• W2038523710 creator A5074218322 @default.
• W2038523710 creator A5083137350 @default.
• W2038523710 date "2008-05-01" @default.
• W2038523710 modified "2023-09-26" @default.
• W2038523710 title "Doxycycline Treatment of<i>Brugia malayi</i>–Infected Persons Reduces Microfilaremia and Adverse Reactions after Diethylcarbamazine and Albendazole Treatment" @default.
• W2038523710 cites W1820500293 @default.
• W2038523710 cites W1963864054 @default.
• W2038523710 cites W1986532204 @default.
• W2038523710 cites W1989064596 @default.
• W2038523710 cites W1995372747 @default.
• W2038523710 cites W2000402496 @default.
• W2038523710 cites W2006218982 @default.
• W2038523710 cites W2030567884 @default.
• W2038523710 cites W2048859905 @default.
• W2038523710 cites W2062802211 @default.
• W2038523710 cites W2066195188 @default.
• W2038523710 cites W2067463717 @default.
• W2038523710 cites W2075083605 @default.
• W2038523710 cites W2078004533 @default.
• W2038523710 cites W2118116578 @default.
• W2038523710 cites W2125206959 @default.
• W2038523710 cites W2126926648 @default.
• W2038523710 cites W2128320197 @default.
• W2038523710 cites W2146935322 @default.
• W2038523710 cites W2149721095 @default.
• W2038523710 cites W2151609412 @default.
• W2038523710 cites W2155338341 @default.
• W2038523710 doi "https://doi.org/10.1086/586753" @default.
• W2038523710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18419441" @default.
• W2038523710 hasPublicationYear "2008" @default.
• W2038523710 type Work @default.
• W2038523710 sameAs 2038523710 @default.
• W2038523710 citedByCount "90" @default.
• W2038523710 countsByYear W20385237102012 @default.
• W2038523710 countsByYear W20385237102013 @default.
• W2038523710 countsByYear W20385237102014 @default.
• W2038523710 countsByYear W20385237102015 @default.
• W2038523710 countsByYear W20385237102016 @default.
• W2038523710 countsByYear W20385237102017 @default.
• W2038523710 countsByYear W20385237102018 @default.
• W2038523710 countsByYear W20385237102019 @default.
• W2038523710 countsByYear W20385237102020 @default.
• W2038523710 countsByYear W20385237102021 @default.
• W2038523710 countsByYear W20385237102022 @default.
• W2038523710 countsByYear W20385237102023 @default.
• W2038523710 crossrefType "journal-article" @default.
• W2038523710 hasAuthorship W2038523710A5014550438 @default.
• W2038523710 hasAuthorship W2038523710A5024279527 @default.
• W2038523710 hasAuthorship W2038523710A5036900827 @default.
• W2038523710 hasAuthorship W2038523710A5056925040 @default.
• W2038523710 hasAuthorship W2038523710A5060467891 @default.
• W2038523710 hasAuthorship W2038523710A5073074999 @default.
• W2038523710 hasAuthorship W2038523710A5074193742 @default.
• W2038523710 hasAuthorship W2038523710A5074218322 @default.
• W2038523710 hasAuthorship W2038523710A5083137350 @default.
• W2038523710 hasBestOaLocation W20385237101 @default.
• W2038523710 hasConcept C126322002 @default.
• W2038523710 hasConcept C141071460 @default.
• W2038523710 hasConcept C142724271 @default.
• W2038523710 hasConcept C165901193 @default.
• W2038523710 hasConcept C197934379 @default.
• W2038523710 hasConcept C203014093 @default.
• W2038523710 hasConcept C204787440 @default.
• W2038523710 hasConcept C27081682 @default.
• W2038523710 hasConcept C2775848585 @default.
• W2038523710 hasConcept C2776158911 @default.
• W2038523710 hasConcept C2777065887 @default.
• W2038523710 hasConcept C2777179404 @default.
• W2038523710 hasConcept C2777411658 @default.
• W2038523710 hasConcept C2777629521 @default.
• W2038523710 hasConcept C501593827 @default.
• W2038523710 hasConcept C71924100 @default.
• W2038523710 hasConcept C86803240 @default.
• W2038523710 hasConcept C89423630 @default.
• W2038523710 hasConcept C90924648 @default.
• W2038523710 hasConceptScore W2038523710C126322002 @default.
• W2038523710 hasConceptScore W2038523710C141071460 @default.
• W2038523710 hasConceptScore W2038523710C142724271 @default.
• W2038523710 hasConceptScore W2038523710C165901193 @default.
• W2038523710 hasConceptScore W2038523710C197934379 @default.
• W2038523710 hasConceptScore W2038523710C203014093 @default.
• W2038523710 hasConceptScore W2038523710C204787440 @default.
• W2038523710 hasConceptScore W2038523710C27081682 @default.
• W2038523710 hasConceptScore W2038523710C2775848585 @default.
• W2038523710 hasConceptScore W2038523710C2776158911 @default.
• W2038523710 hasConceptScore W2038523710C2777065887 @default.
• W2038523710 hasConceptScore W2038523710C2777179404 @default.
• W2038523710 hasConceptScore W2038523710C2777411658 @default.
• W2038523710 hasConceptScore W2038523710C2777629521 @default.

• next